Skip to content

PRESSURE BIOSCIENCES INC

Delisted

CIK 830656fmd_19ZJ5MCN0M7WDPXGCNAW3QVXE9Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2024, 57 periods

Income Statement · Annual · Millions · USD
Line itemFY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023
Total revenues1222221222
Cost of revenue1111111121
Gross profit11111111(0)1
Realized investment gains (losses)––––––1(0)––
Research and development1111111111
Selling, general and administrative3445454449
Total operating expenses556778––––
Operating income(3)(4)(4)91(4)(6)(5)(4)(5)(10)
Interest expense1456458141016
Interest and investment income(1)–––––––––
Other non-operating income (expense)(1)(4)1(6)(5)(6)(11)(16)(11)(20)
Income before taxes––––––––––
Income tax expense–––––(0)––––
Net income from continuing operations––––––––––
Net income(5)(7)(3)(11)(10)(12)(16)(20)(16)(7)
Net income to common shareholders(6)(7)(3)(11)(23)(16)(18)(23)(18)(35)
PRESSURE BIOSCIENCES INC financial statements · FinancialMD